SCHEMBL20760739

SCHEMBL20760739

COC(=O)CC[S+]([O-])Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28615361 0.81 TSHR (0.57)
SCHEMBL8257596 0.80 TSHR (0.50)
SCHEMBL6667055 0.76
SCHEMBL9219488 0.74 TSHR (0.48)
SCHEMBL12997424 0.73
SCHEMBL11895137 0.71 TSHR (0.58)
SCHEMBL28619980 0.71 TSHR (0.46)
SCHEMBL17072517 0.71 TSHR (0.44)
Dimethyl Succinate SCHEMBL28054469 0.71 TSHR (1.00)
Dimethyl Succinate SCHEMBL10213 0.71 TSHR (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773058-B2 Sulfonamide carboxamide compounds INFLAZOME LIMITED (IE) 2023-10-03 US disclosed
US-11773058-B2 Sulfonamide carboxamide compounds INFLAZOME LIMITED (IE) 2023-10-03 US disclosed
US-20200331850-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2020-10-22 US disclosed
WO-2019034696-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2019-02-21 WO disclosed